Research Overview of CJC 1295
CJC 1295 is a growth hormone releasing hormone (GHRH) analogue peptide that has gained significant attention in endocrinological research. This synthetic peptide represents a modified version of GHRH(1-29) with strategic amino acid substitutions at positions 2, 8, 15, and 27, enhancing its stability and research utility. The compound binds selectively to GHRH receptors and stimulates growth hormone secretion in preclinical models, making it valuable for investigating growth hormone axis modulation. Researchers at Stroid UK Shop can access this pharmaceutical-grade material for their investigations into hormonal pathways and endocrine system function.
Laboratory Research Applications
Scientists investigate CJC 1295 in various research contexts, particularly focusing on its interaction with growth hormone regulatory mechanisms. The peptide demonstrates unique pharmacokinetic properties that distinguish it from natural GHRH, offering researchers extended observation windows for studying growth hormone release patterns. Research teams examining CJC 1295 peptide variants often compare this non-DAC version with its longer-acting counterpart to understand duration and intensity of biological responses. Studies typically examine the compound’s effects on pituitary function, growth hormone pulsatility, and downstream IGF-1 responses in controlled laboratory environments. Researchers also investigate potential applications in age-related growth hormone decline models and metabolic dysfunction studies.
Technical Specifications
| Parameter | Value |
|---|---|
| CAS Number | 863288-34-0 |
| Molecular Weight | 3367.97 g/mol |
| Purity | Verify with supplier |
| Form | Lyophilised powder |
| Vial Count | 10 vials |
| Strength | 10iu per vial |
| Manufacturer | Odin Pharmaceuticals |
| Storage | -20°C (lyophilised) |
This Odin Pharmaceuticals formulation provides consistent research material for laboratories investigating growth hormone pathways. Researchers studying broader peptide applications often cross-reference findings with other compounds available in our peptides catalogue, while those examining selective receptor modulators may explore complementary research materials in the SARMs section for comprehensive endocrine studies.
Research Use Compliance
CJC 1295 from Odin Pharmaceuticals is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This product is not intended for human consumption, therapeutic use, or any application outside of controlled laboratory environments. Researchers must ensure compliance with relevant institutional guidelines and maintain proper storage conditions to preserve peptide integrity throughout their investigations.
